what are glp-1 receptor agonists GLP-1 Receptor Agonist Services for
Description
Ro, the leading direct-to-patient healthcare company, today announced that it is working with Eli Lilly to launch the recently FDA-approved Zepbound (tirzepatide) KwikPen nationwide on its platform
Find the Best Option for Your Weight Management Goals.
Both tirzepatide (since 2022) and semaglutide (since 2024) were placed on the shortage list, prompting a surge in sales of compounded alternatives
Side Effects: As a GLP-1 therapy, common side effects are typically gastrointestinal, including nausea, vomiting, and diarrhea.
GLP-1 patches are popping up everywhere online, promising needle-free weight loss support and an easy alternative to injections
